Trusted API Manufacturing Partner Delivering Quality & Innovation
Reine Lifescience is a globally recognized pharmaceutical API manufacturer based in Ankleshwar, India. With cGMP-compliant facilities and advanced infrastructure, we manufacture high-quality Active Pharmaceutical Ingredients for regulated global markets.
Our integrated operations, experienced leadership, strong quality systems, and commitment to regulatory excellence position us as a reliable long-term partner for pharmaceutical companies worldwide.
Advanced API Manufacturing for Global Markets
Reine Lifescience operates cGMP compliant facilities in Ankleshwar delivering high quality Active Pharmaceutical Ingredients to regulated markets worldwide.
- Modern infrastructure with integrated QA QC & R&D
- International regulatory compliance
- Scalable manufacturing capacity
Our Product Range
| # | Product | Category | Specs | Status |
|---|---|---|---|---|
| 1 | Amiodarone HCL | Anti-Arrhythmic | IP / BP / EP / USP / DMF | CEP Not Available |
| 2 | Apixaban | Anticoagulant | IH | Not Available |
| 3 | Atorvastatin Calcium | Cardiovascular | IP / BP / EP / USP | WHO-GMP |
| 4 | Atorvastatin Strontium | Cardiovascular | IH | Not Available |
| 5 | Baclofen | Antispasmodic | IP / BP / EP / USP | WHO-GMP |
| 6 | Benzocaine | Anaesthetics | BP / EP / USP | CEP Approved |
| 7 | Bilastine | Anti-Allergic | IP | Not Available |
| 8 | Deferasirox | Iron Chelator | IP / BP / EP | Not Available |
| 9 | Deferiprone | Iron Chelator | BP / EP | Not Available |
| 10 | Doxofylline | Anti-Asthmatic | IP / USP | WHO-GMP |
| 11 | Ethambutol HCL | Anti-Tubercular | IP / BP / EP / USP | Not Available |
| 12 | Febuxostat | DPP-4 | IH | WHO-GMP |
| 13 | Fenofibrate | Anti-Hyperlipidemic | IP / BP / EP / USP | Not Available |
| 14 | Itopride | Gastro Prokinetic | IH | Not Available |
| 15 | Labetalol HCL | Anti-Hypertension | IP / BP / EP / USP | Not Available |
| 16 | Letrozole | Anti-Estrogen | IP / BP / EP / USP | Not Available |
| 17 | Metoprolol Succinate | Anti-Hypertension | IP / BP / EP / USP | CEP Under Approval |
| 18 | Metoprolol Tartrate | Anti-Hypertension | IP / BP / EP / USP | CEP Under Approval |
| 19 | Minoxidil | Anti-Hypertension | IP / BP / EP / USP | Not Available |
| 20 | Mirogabalin Besylate | Neuropathic Pain | IH | Not Available |
| 21 | Phenylbutazone | NSAID | BP / EP / USP | CEP Approved |
| 22 | Pregabalin | Anti-Epilepsy | IP / BP / EP / USP | CEP Under Approval |
| 23 | Rosuvastatin Calcium | Cardiovascular | IP / BP / EP / USP | MFDS Korea |
| 24 | Sitagliptin Phosphate Monohydrate | DPP-4 | IP / BP / EP / USP | WHO-GMP |
| 25 | Teneligliptin HBr | Anti-Diabetic | IP | Not Available |
| 26 | Teneligliptin HCL | Anti-Diabetic | IH | Not Available |
| 27 | Torsemide | Anti-Hypertension | IP / BP / EP / USP | Not Available |
| 28 | Trazodone HCL | Anti-Depressant | IP / BP / EP / USP | WHO-GMP |
| 29 | Erdosteine | Anti-Mucolytic | IH | DMF |
| 30 | Bempedoic Acid |
| 31 | Fimasartan |
| 32 | Iopamidol |
| 33 | Luliconazole |
| 34 | Minoxidil Sulphate |
Reine’s API Expertise: Capabilities at a Glance
At Reine Lifescience, we deliver integrated API manufacturing capabilities aligned with global regulatory standards, ensuring quality, scalability, and reliability.
Three Decades of Excellence
From chemical intermediates to a globally-recognised pharmaceutical API manufacturer —
our journey defined by quality and commitment.
Established as Reine Chemicals Pvt. Ltd.
Foundation laid with a vision to manufacture high-quality chemical intermediates.
Transition to Reine Lifescience
Strategic expansion into pharmaceutical APIs and regulated markets.
WHO Inspection
Successful WHO inspection strengthening global regulatory credibility.
CEP Customer Audit
Reinforcing regulatory alignment and quality excellence.
WHO-GMP Approval
Demonstrating advanced manufacturing compliance standards.
MFDS Korea Approval
Expanded regulatory footprint in Asian pharmaceutical markets.
Sri Lanka Audit
Reinforcing regulatory alignment and quality excellence.
Anvisa Inspection Completed
Strengthening regulatory presence across Latin America.
International Expo & Events
Meet us at leading pharmaceutical exhibitions across the globe
CPHI CHINA
June 2026 · Shanghai
CPHI THAILAND
July 2026 · Bangkok
CPHI KOREA
August 2026 · Seoul
CPHI CHINA
June 2026 · Shanghai
CPHI THAILAND
July 2026 · Bangkok
CPHI KOREA
August 2026 · Seoul
CPHI Frankfurt
Oct 2025 · Germany
CPHI India
Nov 2025 · India
CPHI Frankfurt
Oct 2025 · Germany
CPHI India
Nov 2025 · India